Novel Antithrombotics in Geriatric PCI for STEMI: Balancing Ischemic Protection with Bleeding Risk: Short title: Novel Antithrombotics in Geriatric PCI for STEMI. [PDF]
Pakizeh I, Sohrabi B.
europepmc +1 more source
Optimal Antithrombotic Therapy for Peripheral Artery Disease: A Systematic Review and Network Meta-Analysis. [PDF]
Hiruma Y +9 more
europepmc +1 more source
Ticagrelor Versus Clopidogrel in Patients With ST-Elevation Myocardial Infarction and Elevated Platelet Counts: A Multicenter Comparative Analysis of Ischemic Outcomes. [PDF]
Ji FJ +11 more
europepmc +1 more source
Pharmacodynamic effects of cangrelor in patients with or without STEMI undergoing percutaneous coronary intervention: insights from the POMPEII study. [PDF]
Gargiulo G +19 more
europepmc +1 more source
Ticagrelor Versus Clopidogrel or Aspirin in Secondary Stroke Prevention: Systematic Review and Meta-Analysis of Randomized Controlled Trials. [PDF]
Zaihan AF +4 more
europepmc +1 more source
The Safety Profile of Ticagrelor among Older Adults (Age ≥75 years): A Pharmacovigilance Analysis.
Yacoby-Halevi I +16 more
europepmc +1 more source
Case Report: Intravascular lithotripsy combined with a new-generation 3-in-1 carotid stent for calcified carotid artery stenosis. [PDF]
Ertl WJP, Verma U, Shakir HJ, Jen S.
europepmc +1 more source
Modern Era in Personalized Medicine of Dual Antiplatelet Therapy After Myocardial Revascularization. [PDF]
Dehghan A +3 more
europepmc +1 more source
Percutaneous Coronary Interventions: Bleeding Risk Assessment and Management. [PDF]
Salihu A +7 more
europepmc +1 more source
CYP3A4, CYP3A5, and CYP4F2 Polymorphisms and Bleeding Risk in Ticagrelor-Based Dual Antiplatelet Therapy. [PDF]
Dakić S +13 more
europepmc +1 more source

